AzTrials
AzTrials

Cerebellar AtaxiaNCT04039048

Effect of ctDCS During Balance Training on Cerebellar Ataxia

A study testing cerebellar transcranial direct current stimulation and Balance training in people with Cerebellar Ataxia and Cerebellum; Injury, run by Universidade Federal de Pernambuco at 1 site in Brazil.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Cerebellar ataxia is a neurologic symptom caused by damage or dysfunction in the cerebellum and its pathways that results in loss of coordination, balance and postural control. There is a high rate (93%) of fallings for this population that could limit daily life activities. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Cerebellar Ataxia, Cerebellum; Injury, Balance
What is being tested?
cerebellar transcranial direct current stimulation and Balance training
Type of treatment
Medical device
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
10 participants
Where
1 siteBrazil
Study dates
Sep 2019to Mar 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Cerebellar ataxia
  • Score > 1 ≤ 4 on posture of Scale for assessment and rating of ataxia

Who cannot join

  • Individuals with other neurological disorders, postural hypotension, vestibular, visual, cardiovascular or musculoskeletal disorders that affect the performance of the proposed tests;
  • Pacemaker;
  • History of seizures;
  • Metallic implants in the head or neck;
  • Medication change (3 months) during the period of study

Trial locations and contacts

1 site in 1 country.

Kátia Monte-Silva, PhD contact

+55 81 2126-7579

monte.silvakk@gmail.com

Brazil1 site, 1 recruiting
  • Kátia Monte-Silva

    Recife, Pernambuco, 50670-901

    Kátia Monte-Silva, PhD, +55 81 2126-7579, monte.silvakk@gmail.com

    Recruiting

Other trials in Brazil

About this study

Official title: Effects of Cerebellar Transcranial Direct Current Stimulation During Balance Training on Cerebellar Ataxia

Cerebellar ataxia is a neurologic symptom caused by damage or dysfunction in the cerebellum and its pathways that results in loss of coordination, balance and postural control. There is a high rate (93%) of fallings for this population that could limit daily life activities. Pharmacological interventions are not able to modify the balance, therefore, new approaches to rehabilitate must be studied. ctDCS is a non-invasive brain stimulation that seems to be a new and innovator technique to restore ataxia symptoms. The purpose of this study is to evaluate the effects of ctDCS associated with balance training on cerebellar ataxia patients. A counterbalanced crossover, sham-controlled, triple blind trial will be performed. All subjects will receive the real and sham ctDCS associated to balance training. The anodal ctDCS (2 mA, 20 minutes) or sham (2mA, 30 seconds) will be applied during balance training at Biodex Balance System (BBS). The balance will be the primary outcome and will be evaluated through Posture Control at Biodex Balance System. Ataxia' severity and functional mobility will be the secondary outcomes and will be evaluated by the scale for the assessment and rating of ataxia (SARA) and 10 meters walking test, respectively.

Being tested
cerebellar transcranial direct current stimulation, Sham cerebellar transcranial direct current stimulation, Balance training
Keywords
Biodex balance system, Posture control, Ataxia' severity, ctDCS
Medical subject headings
Cerebellar Ataxia, Wounds and Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • cerebellar transcranial direct current stimulationDevice

    Also called ctDCS

    Non-invasive brain stimulation technique is able to modulate the brain activity through a low-intensity current. The anodal will be positioned 1 cm below inion and cathodal in the right deltoid muscle. 20 minutes with a 2mA current.

  • Sham cerebellar transcranial direct current stimulationDevice

    Also called ctDCS sham

    Non-invasive brain stimulation technique is able to modulate the brain activity through a low-intensity current. The anodal will be positioned 1 cm below inion and cathodal in the right deltoid muscle. 30 seconds with a 2mA current.

  • Balance trainingOther

    Balance training will be performed through the Biodex Balance System for 20 minutes.

Study groups in NCT04039048
Study groupRoleWhat they receive
ctDCS during Balance trainingExperimentalNot described
Receives: Device: cerebellar transcranial direct current stimulation; Other: Balance training
ctDCS sham during Balance trainingSham comparatorNot described
Receives: Device: Sham cerebellar transcranial direct current stimulation; Other: Balance training

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in balance

    The change in balance will be assessed through postural control index of Biodex Balance System. This postural control index is a continuous variable where lower index means less instability and better balance.

    Measured: 5 minutes before the intervention and 10 minutes after the intervention

Secondary outcomes (2)
  1. Change in Ataxia' severity

    The ataxia' severity will be assessed by the Scale for the Assessment and Rating of Ataxia (SARA). It consists of eight items (gait, stance, sitting, speech disturbance, finger chase, nose-finger test, fast alternating, hand movements, and heel-shin slide), where higher score (40) mean more severe ataxia, whereas lower score (0) means less ataxia symptoms. The score happens about the sum of the eight items.

    Measured: 10 minutes before the intervention and 15 minutes after the intervention

  2. Change in functional mobility

    The patient will walk 10 meters and the time will be measured to determine the functional mobility. Where lower time to walk 10 meters, better functional mobility.

    Measured: 15 minutes before the intervention and 20 minutes after the intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted31 Jul 2019
  2. Study startSep 2019 (estimated)
  3. Primary completionFeb 2020 (estimated)
  4. Study completionMar 2020 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
10 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04039048
Sponsor's protocol ID
cerebellarataxia_balance_ctDCS
Status last verified
Aug 2019
First submitted
28 Jul 2019
Last updated
16 Aug 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Brito R, Fabricio JV, Araujo A, Barreto G, Baltar A, Monte-Silva K. Single-Session Cerebellar Transcranial Direct Current Stimulation Improves Postural Stability and Reduces Ataxia Symptoms in Spinocerebellar Ataxia. Cerebellum. 2024 Oct;23(5):1993-2002. doi: 10.1007/s12311-024-01696-9. Epub 2024 May 2.

    PubMed 38693314

Questions about this trial

What is this clinical trial studying?

A study testing cerebellar transcranial direct current stimulation and Balance training in people with Cerebellar Ataxia and Cerebellum; Injury, run by Universidade Federal de Pernambuco at 1 site in Brazil.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 16 Aug 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Brazil. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Kátia Monte-Silva, PhD (+55 81 2126-7579, monte.silvakk@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in balance (time frame: 5 minutes before the intervention and 10 minutes after the intervention). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04039048, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Aug 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in